Friday, April 9, 2010

Sherwin Rodrigues bags the title of Bayer National Scrabble Championship 2010 third time in a row

Bayer CropScience is resuming production – except for the active ingredient Ethoprophos – at its plant in Ankleshwar after having been granted three month production allowance by the relevant authorities in Gujarat. The company is confident that within this three month period it will be able to answer all questions of the authorities in a satisfactory manner.

Bayer CropScience has been asked to halt manufacturing activities at the Ankleshwar site on March 22, 2010, subsequent to a fire that broke out at a storage tank earlier in the month. The site of fire, Agro-Chemicals Plant 4 (AC IV) will, however, not resume operations at this moment. Bayer CropScience and the authorities are in the final stages of their investigation process.

Contact for Bayer CropScience:

Aloke Pradhan
V.P. - Corporate Communication
E mail : aloke.pradhan.ap@bayer.com
Telephone : +91 22 2571 1234

About Bayer CropScience
Bayer is a global enterprise with core competencies in the fields of health care, nutrition and high-tech materials. Bayer CropScience AG, a subsidiary of Bayer AG with annual sales of about EUR 6.5 billion (2009), is one of the world’s leading innovative crop science companies in the areas of crop protection, non-agricultural pest control, seeds and traits. The company offers an outstanding range of products and extensive service backup for modern, sustainable agriculture and for non-agricultural applications. Bayer CropScience has a global workforce of 18,700 and is represented in more than 120 countries.

Forward-Looking Statements
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.

Copyright © Bayer AG